Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 495 (TSX: $TGOD.TO) (OTC: $TGODF) (OTCQB: $AMMJ) (TSX: $FIRE.TO) (CSE: $RVV.C)
Delta, Kelowna, BC, November 12, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/111220-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/11121TGOD-AMMJ-FIRE-RVV.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public announcements.
American
Cannabis Company, Inc. (OTCQB:
AMMJ), a full-service business-to-business cannabis and
hemp consulting solutions provider, announced its
approval for an Operator’s License by Colorado’s Marijuana Enforcement Division
(MED).
On November 10, 2020, Colorado’s
Marijuana Enforcement Division (MED), approved the Company’s application for an
Operator’s License, allowing it to now manage and operate both recreational and
medical cannabis operations throughout Colorado. This recent approval is key in
the Company’s plan to effectively roll out its management services to operators
who seek to improve their overall business efficiencies. In addition to this
approval for an Operator’s License, the Company recently received MED approval
for a Suitability License, establishing the Denver-based company as one of the
few publicly traded companies authorized to acquire and operate various
cannabis licenses throughout Colorado.
Terry Buffalo, Chief Executive
Officer of American Cannabis Company, commented, “We are happy to now have the
ability to deploy our operational management platform across the Colorado
market as we seek to continually expand our service offerings. We provide our
suite of management services to those who may need guidance in various areas of
business related to cultivation, retail or extraction operations. In having
secured both suitability and operators licenses within Colorado, we now have a
multi-pronged approach in advancing our brand forward in this market. As we
effectively work to implement our growth strategies, we will actively deploy
our management platform while continuing to pivot our business model and
advance brand expansion efforts by looking at multiple operational acquisition
opportunities.”
The
Supreme Cannabis Company, Inc. (TSX:
FIRE) (OTCQX:
SPRWF) announced that
the Company has entered into a supply agreement with Medical Cannabis by
Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc.
Under the terms of the supply
agreement with Medical Cannabis by Shoppers Inc., the Company will offer
Truverra-branded medical cannabis products through the Medical Cannabis by
Shoppers™ online sales platform accessible to patients across Canada.
"This is an important
development that establishes Truverra as a valuable medical cannabis brand and
provides further diversification of our revenue," said Beena Goldenberg,
President and CEO of Supreme Cannabis. "We are particularly pleased to introduce
Truverra to Canadian patients, who will be able to order dried flower,
pre-rolls and full-spectrum CBD oil. Included in our offering will be our Jean
Guy strain, which is a tribute to the legendary variety offered by the Montreal
Compassion Club. Also, through the Shoppers portal, patients can be assured of
expert customer service from a trusted brand."
The Medical Cannabis by Shoppers online platform is a convenient and
trusted source of quality medical cannabis, providing patients with single-source
access to a broad range of products. Through their national online platform,
the Medical Cannabis by Shoppers
business connects patients with cannabis products that meet the highest quality
and safety standards and provides guidance and support via a dedicated team of
cannabis-trained advisors and Pharmacists.
Revive
Therapeutics Ltd. (CSE:
RVV)
(OTC:
RVVTF), a specialty life sciences company focused on the
research and development of therapeutics for medical needs and rare disorders, provided
an update on its oral thin-film delivery system with psilocybin
being developed under a research partnership agreement with Reed Research Group
out of the University of Wisconsin-Madison.
Following several months of
prototyping on a wide range of dosage forms, the Company has completed an oral
thin-film strip product with psilocybin with dosage forms ranging between 1 mg
and 20 mg and demonstrating its versatility through physio-chemical characterization
(e.g. tensile strength of films) of bio comparable tannin-chitosan composite
materials, dissolution and disintegration testing, and rate of psilocybin
release from composites. Currently
technical and scientific data is being processed and finalized.
“We are very pleased to have
achieved this development milestone of our orally dissolvable thin film strip
for psilocybin, which can be used in FDA human clinical studies and as a unique
product for medical use in states where psilocybin therapy use is permitted,
such as Oregon following the passage of Measure 109,” said Michael Frank, CEO of Revive. “There is a significant market opportunity
for our unique oral thin film strip technology for not only delivering
psilocybin but also delivering numerous psychedelic-based medicines to treat
various diseases and disorders that would benefit from such a delivery method.
Also, we are in a position to begin partnering with life sciences companies
seeking to add unique offerings in their psychedelic-based product pipeline and
with companies operating in the U.S. where psilocybin therapy use is legal.”
Under its sponsored research
partnership with the Reed Research Group out of the University of
Wisconsin-Madison, the Company is developing its tannin-chitosan composite of
orally dissolvable thin films which offers a unique delivery platform for
therapeutic doses (1-20mg) of psilocybin into the oral cavity. The Company has
finalized the prototypes and is preparing to scale for manufacturing for future
clinical studies involving psilocybin and other psychedelic-derived medicines.
There are a number of advantages and
benefits of an orally dissolvable psilocybin thin film such as the rapid
dissolving and onset of action to the bloodstream, the ease and convenience for
patients to administer without the need of water, chewing or swallowing, the
potential of improved therapeutic outcomes and efficacy for underserved
diseases and disorders including the flexibility to create accurate dosing and
tasteful options.
The
Green Organic Dutchman Holdings Ltd. (TSX:
TGOD) (OTC:
TGODF), announced its
financial results for the third quarter of 2020 ended September 30, 2020, and
leadership changes. These filings are
available for review on the Company's SEDAR profile at www.sedar.com.
The Company also announced that
Brian Athaide has left his positions as Chief Executive Officer
("CEO") and board director effective immediately. TGOD Chief Financial
Officer, Sean Bovingdon, has been appointed Interim CEO. In addition, Michel Gagné, Vice President of
Operations, has been appointed Chief Operating Officer ("COO"),
overseeing the Company's cultivation and processing operations, supply chain
and product development. In his new role
as COO, he will work closely with the CEO on the Company's overall strategy and
execution.
The board of directors decided that
a change in leadership was necessary to drive the Company forward as it enters
its next phase of growth and continues to work towards achieving positive
EBITDA and cash flow as rapidly as possible. Under the Company's new
leadership, TGOD will operate with a renewed commitment to executional
excellence and cost discipline as the Company drives revenue growth and
operational stability.
"On behalf of the board of
directors, we thank Brian Athaide for his contribution to TGOD and I am pleased
that Sean has agreed to lead the Company at this critical juncture,"
commented Jeff Scott, Chairman of the board.
"He recognizes the challenges we must confront, and I look forward
to working with him and the rest of the TGOD team to pave a new way forward for
the Company," added Mr. Scott.
"During the third quarter,
despite certain production challenges that have now been addressed, we
continued to deliver growth following the launch of our mainstream brand,
Highly Dutch, in Quebec as well as teas and RIPPLE dissolvable powders. Our focus will continue to be on improving
the execution of our existing production while developing innovative and
distinctive products to introduce into more stores across the country,"
commented Sean Bovingdon, Interim CEO of TGOD.
"We saw encouraging numbers in October as we sold more flower,
additional RIPPLE and tea variants, and launched hash in Quebec. We are looking to build on this growth while
focusing on financial discipline throughout the Company," added Mr. Bovingdon.
Some of the financial highlights included:
● Total
revenue of $5.71 million, an increase of 119% over Q3-2019
● Canadian
cannabis revenue of $3.84 million, an increase of 41% quarter over quarter
● Loss
from operations reduced by 68% to $6.34 million compared to Q3-2019
● G&A
expenses continue to decrease, down to $5 million for the quarter
●
Company records non-cash impairment charge
of $67.84 million
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Investors can trade these stocks
and other ideas on our site using our list of top stock trading
apps including Robinhood, Acorn,
Stash and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory